Selected Publications

Belbachir N, Portero V, Al Sayed ZR, Gourraud J-B, Dilasser F, Jesel L, Guo H, Wu H, Gaborit N, Guilluy C, Girardeau A, Bonnaud S, Simonet F, Karakachoff M, Pattier S, Scott C, Burel S, Marionneau C, Chariau C, Gaignerie A, David L, Genin E, Deleuze J-F, Dina C, Sauzeau V, Loirand G, Baró I, Schott J-J, Probst V, Wu JC, Redon R, Charpentier F, Le Scouarnec S.
RRAD mutation causes electrical and cytoskeletal defects in cardiomyocytes derived from a familial case of Brugada syndrome.
Eur. Heart J.

Huchet* F, Kyndt* F, Barc* J, Thollet A, Charpentier F, Redon R, Schott JJ, Le Marec H, Probst V, Gourraud JB.
Familial Catecholamine-Induced QT Prolongation in Unexplained Sudden Cardiac Death.
J Am Coll Cardiol 2017;69:1642–1643. * equal contrinution as first or last author.

Derangeon* M, Montnach* J, Cerpa CO, Jagu B, Patin J, Toumaniantz G, Girardeau A, Huang CLH, Colledge WH, Grace AA, Baró I, Charpentier F.
Transforming growth factor β receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease.
Cardiovasc Res 2017;113:464–474. * equal contrinution as first or last author.

Portero V*, Le Scouarnec S*, Es-Salah-Lamoureux Z*, Burel S, Gourraud JB, Bonnaud S, Lindenbaum P, Simonet F, Violleau J, Baron E, Moreau E, Scott C, Chatel S, Loussouarn G, O'Hara T, Mabo P, Dina C, Le Marec H, Schott JJ, Probst V, Baró I, Marionneau C, Charpentier F*, Richard Redon*.
Dysfunction of the voltage-gated K+ channel beta-2 subunit in a familial case of Brugada syndrome.
J Am Heart Assoc 2016; 5: e003122. * equal contrinution as first or last author.

Es-Salah-Lamoureux Z, Jouni M, Malak OA, Belbachir N, Al Sayed ZR, Gandon-Renard M, Lamirault G, Gauthier C, Baró I, Charpentier F, Zibara K, Lemarchand P, Beaumelle B, Gaborit N, Loussouarn G.
HIV-Tat induces a decrease in I(Kr) and I(Ks)via reduction in phosphatidylinositol-(4,5)-bisphosphate availability.
J Mol Cell Cardiol 2016; 99: 1-13.

Jouni M, Si-Tayeb K, Es-Salah-Lamoureux Z, Latypova X, Champon B, Caillaud A, Rungoat A, Charpentier F, Loussouarn G, Baró I, Zibara K, Lemarchand P, Gaborit N.
Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome.
J Am Heart Assoc 2015; 4: e002159.

Béziau DM, Barc J, O'Hara T, Le Gloan L, Amarouch MY, Solnon A, Pavin D, Lecointe S, Bouillet P, Gourraud J-B, Guicheney P, Denjoy I, Redon R, Mabo P, Le Marec H, Loussouarn G, Kyndt F, Schott J-J, Probst V, Baró I.
Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations.
Basic Res Cardiol 2014;109: 446.

Laurent G*, Saal S*, Amarouch MY*, Béziau DM, Marsman RFJ, Faivre L, Barc J, Dina C, Bertaux G, Barthez O, Thauvin-Robinet C, Charron P, Fressart V, Maltret A, Villain E, Baron E, Mérot J, Turpault R, Coudière Y, Charpentier F, Schott J-J, Loussouarn G, Wilde AAM, Wolf J-E, Baró I*, Kyndt F*, Probst V*.
Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy.
J Am Coll Cardiol 2012;60:144-156. * equal contribution as first or last author

Awards

Patents